Dr. Arnoud J. Groen
Tennis Court Road
United Kingdom

twitter: @ArnoudJGroen


I have over 6 years of experience with protein based Mass Spectrometry and now my goal is to apply this to clinical questions. Which proteins are important for the development of diseases? Are there protein predictors that could help judging which treatment works best and how does this differ from person to person? After identifying which proteins could possibly play a role in your system of interest, the next step is to validate that these proteins indeed play a role. The latter is done by measuring only this subset of all proteins, a process called Targeted Proteomics, which is the central part of my work.

Proteomics, the large scale study of proteins, makes it possible to look at thousands of proteins at the same time in any given biological system. This is important if you would like to gain an overview of what is happening at the protein level e.g. during the development of a disease or upon the action of a hormone. Although there is a vast amount of proteomics information being generated, it remains a challenge to understand the biological meaning.


I have a strong interest for interdisciplinary research and to build bridges between science, industry, entrepreneurship and policy. This is to my opinion needed for answering clinically relevant questions with cutting edge technology. My broad approach is exemplified by my positions as treasurer of the Cambridge University Science and Policy Exchange (CUSPE), Vice-President of the Cambridge University Technology and Enterprise Club and President of the first European Life Sciences for Young Scientists conference organised by the Genomics Network for Young Scientists in The Netherlands. 


Before my work in Cambridge, I have done a PhD in Biochemistry at the Hubrecht Institute for Developmental Biology in Utrecht, The Netherlands. I am a graduate in Biomedical Sciences, University of Utrecht and have worked at the European Molecular Biology Laboratory (EMBL) in Grenoble, France.